IL23909A - Benzenesulfonyl-ureas and process for preparing them - Google Patents
Benzenesulfonyl-ureas and process for preparing themInfo
- Publication number
- IL23909A IL23909A IL23909A IL2390965A IL23909A IL 23909 A IL23909 A IL 23909A IL 23909 A IL23909 A IL 23909A IL 2390965 A IL2390965 A IL 2390965A IL 23909 A IL23909 A IL 23909A
- Authority
- IL
- Israel
- Prior art keywords
- carbon
- formula
- carbon atoms
- point
- alkyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- -1 hexenylmethyl group Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical group C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 238000002844 melting Methods 0.000 description 18
- 230000008018 melting Effects 0.000 description 18
- 239000002253 acid Substances 0.000 description 14
- 235000013877 carbamide Nutrition 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000003672 ureas Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001714 carbamic acid halides Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241001547070 Eriodes Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GJJAKJNPJXXMCY-UHFFFAOYSA-N [K].CC(C)=O Chemical compound [K].CC(C)=O GJJAKJNPJXXMCY-UHFFFAOYSA-N 0.000 description 1
- KBTJYNAFUYTSNN-UHFFFAOYSA-N [Na].OO Chemical compound [Na].OO KBTJYNAFUYTSNN-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 150000008331 benzenesulfonamides Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 229940112021 centrally acting muscle relaxants carbamic acid ester Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910000474 mercury oxide Inorganic materials 0.000 description 1
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
E G PAT AT TO RN EYS LEVONTIN 1169 T E L A V I V P A T E S D E S I G N S O R D I N A C E SPECIFICATION AND PR0CE33F0R PREPARING THEM HOECHST Lucius a of Frankfurt am REBY DECLARE the nature of this invention and in what manner the same is to be performed to be particularly described and ascertained in and by the following Pile The present invention relates to ureas corresponding to in which Ί X represents naphthalene or indene which may be or wholly hydrogenated in one ring and which may be linked to the adjacent carbonyl group by a lower alkylene or lower or Z represents lower with 1 to 4 carbon lower alkoxy with 1 to 4 carbon hydroxy or lower represents lower alkyl with 1 to 4 carbon atoms or lower alkoxy with 1 to 4 carbon Y represents a saturated aliphatic hydrocarbon group containing 1 to 5 carbon atoms and represents alkyl of 2 to 8 carbon cycloalkyl with 5 to 8 carbon lower alk or lower alkyl having 7 to 9 carbon atoms of which 6 to 8 belong to the cycloalkyl an or hexenylmethyl group containing 1 or 2 carbon atoms in the endoalkylene In the above and following definitions Slower always means radicals with 1 to carbon atoms in a straight or branched stands an radical anic acid having up to 4 carbon preferably a straight chain or branched alkanoyl radical of the indicated chain may fo straight o branched or Within the scope of the invention there are icularly preferred compounds containing as a cycloalkyl or cycloalkenyl hydrocarbon may be stituted by alkyl or alkoxy or linked to the nitrogen atom by means of Said radicals cyclooctyl and and The alkyl or alkoxy groups may stand or preferably well as in Cyclic systems which enter into consideration as basic skeleton for the member X of the general formula are particularly those with 8 to 10 carbon for instance or the correspondin systems which are partially or wholly hydrogena ed in one such as tetrahydronaphthalene among the partially ring systems there are preferred those in which an aromatic and a saturated cycloallphatic nucleus are linked with one The ring system may be to the adjacent earbonyl group any In the case of partially hyd ogenated systems the linkage may in the aromatic as as in the hydrogenated part of the ring a linkage to the aromatic part being Linkage may likewise be effected via a lower alkylene for or or furthermore via group The substituents Z and may be likewise linked to the rin system X any for one stltuent the to the earbonyl group being As examples for the bridge member Y there are File As examples for the Z or there are or butyl as well as the ponding alkoxy bromine or chlorine being the preferred It may contain the remaining parts of the molecule o in or to one the being The present invention furthermore relates to a process for preparing the said The cess is characterized in that acid acid acid or ureas carrying the substituent are reacted with amines if their if are used in which Z OH this radical protected by benzylation or esteri benzenesulfonamides of the formula ZZ H2 or their salts are reacted with carbamic acid acid carbamic acid halides or ureas or correspondingly substituted benzenesulfonyl are reacted with or parabanic acids and the benzenesul or acids obtained this way or by another method are in correspondingly substituted thioureas the sulfur atom is replaced by an oxygen corresponding benzenesulfonyl ureas or are one or several reaction the radical is introduced by of formula in of the in which Z is a hydroxy group protected by or etheri the hydroxy group is split of by catalytic genation or and the products obtained are treated with alkaline if Instead of the there may also be used reaction products of isocyanates with acid amides such as caprolactam or or with weakly basic amines such The acid esters or zenesul acid esters may carry in the alcohol component a low molecular weight alkyl radical or a phenyl The same applies to the stituted carbamic acid esters or the corresponding monothiocarbamic acid As carbamic acid halides the chlorides are used the first The to be used as starting substances may be unsubstituted at the sid of the urea opposite to sulfonyl group or may be stituted once or twice by alkyl radicals or Instead of benzenesul substituted in this manner there be used corresponding and this case acyl stands for an phatic carboxylic acyl group with up to carbon atoms or a benzoyl It is possible for to treat such or with amines of the mula R 1 and to heat the salts obtained to elevated temperatures especially a temperature above It is likewise possible to start from ureas of the formula or from acylated ureas of the formula wherein represents an aliphatic or aromatic carboxylic acid radical preferably of molecular or the nltro or from of the formula R or from of the formula wherein the phenyl radicals may be substituted and may be linked with one another directly or by means of a bridge member such as or or from ureas of the formula and to react the said compounds with tuted In the correspondingly substituted benzenesulfonyl thioureas the sulfur atom can be replaced by an ozygen for example with the aid of oxides or salts of heavy metals or by the use of oxidizing agents such as hydrogen peroxide sodium peroxide or nitrous The can likewise be desulfurized by treatment with phosgene or phosphorus acid amidines or chloroformic acid obtained as ates can be converted into the by an appropriate for instance by hydrolysis or addition of When the products of the invention are prepared from intermediates the hydroxy group of which is benzylated or the final products obtained may be converted into the claimed by a conventiona The groups may be split off by catalytic hydrogenation and ester groups may be split off by acid or alkaline As regards the reaction the forms of realizing process of the invention in vary within wide limits and can be adapted to each vidual For the reactions can be carried out with the use of at room temperature or at elevated As starting substances there are on the one compounds containin a benzene radical substituted NH by the group As examples for the ponent of the said formula there are mentioned without the enumeration being the following radicals The lowerin action of the urea derlTatives according to the invention could be by feeding to rabbits in a dose of 10 milligrams kilogram and determining the blood sugar value according to the known method of or by means of an autoanalyzer over a roloned eriod of V it was for that 10 of provokes after 3 hours a lowering of the blood sugar of while the known has no blood sugar lowering properties to rabbits in a dose of less than 25 The products according to the invention are ably destined for the manufacture of orally preparations showing blood sugar lowering action in the treatment of diabetes melli us and can be applied as such or in the form of their salts or in the presence of stances causing salt For the formation of salts there can be for alkaline agents such as alkali metal hydroxides alkaline earth metal alkali metal carbonates or alkaline earth metal carbonates or As pharmaceutical parations there enter into consideration preferably tablets in addition to the products of the the usual adjuvants and carriers such as or magnesium A preparation containing the abovementioned active for instance a tablet or a with or without the aforesaid is advan ageously brought into a suitable dosage unit The dose chosen should comply with the activity of the used and the desired the dosage per unit amounts to about to 100 preferably 2 to 10 but ably higher or lower dosage units may likewise be if are divided or multiplied prior to their The following examples serve to illustrate the invention but they are not intended to limit it Example 1 15 Grams of sulfonamide point were while in 130 milliliters of acetone and 22 milliliters of 2N NaOH while grams of were dropped The dropwise addition being the temperature was allowed to rise slowly and the reaotion mixture was stirred at room temperature for 3 hours The reaotion mixture filtered with the acetone was removed under reduced pressure in a rotary evaporator at room ature and the residue was crystallized from methyl Melting 225 In analogous manner there were meltin oint from methanolwater melting point from a large amount of ethanol o dimethyl melting point from from point the melting point from the melting point from from point the melting point 195 from melting point 190 from methanol and melting point 170 from from amide point the melting point 183 from from ethanol and melting point from from s lfonamide point the melting point from from point the melting point from In an analogous manner there From point the point 208 C from the o point 203 the point 13 5 Grams of were while to 22 grams of point in 120 milliliters temperature was raised to whereby reaction set in with splitting off of The reaction mixture was cooled after about 30 the precipitated urea was filtered off with suction recrystallized from It had a of Example 3 Grams of 2 ether pared by reacting 2 benzenesulfonyl with mercury oxide in melting point 114 and 30 milliliters of concentrated hydrochloric acid were heated for 5 minutes on the steam The precipitate which solidified on cooling was recrystallized from melting point The mixed melting point with the substance pared by a different method showed no Example 4 Grams of 2 by reacting 2 sulfonamide with oil in the presence of potassium acetone and dimethyl ing point 137 after reorganization from acetic NaOH and hydrogen peroxide of strength was was for a short time on the steam it allowed to filtered and the filtrate was The precipitated was from It had a melting point of Example 5 Grams of sodium point of the free fonamide 173 and 22 grams of in 40 milliliters of dimethyl formamide were maintained for 7 hours at The reaction mixture was water was added and the ture was rendered alkaline by means of 2N The phenylamine formed was extracted with the aqueous phase was treated with coal and The precipitate was extracted with of acidified and reorystallized from The product obtained had a melting point 167 Example 12 Grams of point 201 350 milliliters of grams of glacial acetic acid and grams cyclohexylamine were stirred for 3 hours at The reaotion mixture was concentrated under reduced pressure and the residue Was treated with ammonia of the extract was acidified and the reaction product was recrystallized from had a Example 7 10 Grams of sodium were thoroughly mixed with 5 grams of ground potassium carbonate and 10 grams of cyclohexyl carbamio acid ester point and while stirring occasional the whole is heated for 3 hours at C on oil After water and the excess carbamio acid ester is removed by shaking out with The aqueous solution is then filtered with suction and crystallized from Melting point 17 In an analogous manner to Example 2 there were obtainedι Prom o ethyl 187 the point from and the point 169 from from urethane point the point from and the point from from point the point from and point from insufficientOCRQuality
Claims (1)
1. File WHAT IS CLAIMED A of the general formula in which X represents naphthalene or indene which may be partially or wholly hydrogenated in one ring and which may be linked to carbonyl group by a lower alkylene or lower or Z represents lower with 1 to 4 carbon lower alkoxy with 1 to 4 carbon hydroxy or represents lower alkyl with 1 to 4 carbon atoms or lower alkoxy with 1 to 4 carbon T represents a saturated aliphatic hydrocarbon group containing 1 to carbon atoms and represents alkyl of 2 to 8 carbon cycloalkyl with 5 to 8 carbon lower or alkyl having 7 to 9 carbon atoms of which 6 to 8 belong to the cycloalkyl an or hexenylmethyl group containing 1 or 2 carbon atoms in the endoalkylene A physiologically tolerable salt of a A process for preparing blood sugar lowering pharmaceutical preparations are suitable for oral treatment of diabetes which comprises processing as claimed in Claim 1 or if in admixture with pharmaceutically acceptable adjuvants and a dosage unit Blood sugar lowering pharmaceutical preparations suitable for the oral treatment of containin one of the defined in 1 or as the active of the formula 23 Fw 4531 B 6 of the formula of the formula 8 2 l of the formula 2 the formula Pw 4531 B ethyl N of the DATED SHIS 6th day of COHEN SPISBACH 1169 TEL AVIV Attorneys fo insufficientOCRQuality
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF0043451 | 1964-07-16 | ||
| LU47779A LU47779A1 (en) | 1964-07-16 | 1965-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL23909A true IL23909A (en) | 1971-02-25 |
Family
ID=25976358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL23909A IL23909A (en) | 1964-07-16 | 1965-07-07 | Benzenesulfonyl-ureas and process for preparing them |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS4838698B1 (en) |
| AT (6) | AT266157B (en) |
| BE (1) | BE667035A (en) |
| BR (1) | BR6571355D0 (en) |
| CH (1) | CH469679A (en) |
| CY (1) | CY477A (en) |
| DK (5) | DK118553B (en) |
| FI (1) | FI45954C (en) |
| GB (1) | GB1106616A (en) |
| IL (1) | IL23909A (en) |
| IS (1) | IS722B6 (en) |
| MC (1) | MC545A1 (en) |
| MY (1) | MY6900216A (en) |
| NL (1) | NL149159B (en) |
| NO (1) | NO117176B (en) |
| OA (1) | OA02022A (en) |
| SE (5) | SE325020B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS499100A (en) * | 1972-05-22 | 1974-01-26 | ||
| JP4737084B2 (en) * | 2004-03-12 | 2011-07-27 | 堺化学工業株式会社 | Amide compound, pharmaceutical composition and RXR function regulator |
-
1965
- 1965-03-29 GB GB13221/65A patent/GB1106616A/en not_active Expired
- 1965-07-07 IL IL23909A patent/IL23909A/en unknown
- 1965-07-09 DK DK352665AA patent/DK118553B/en unknown
- 1965-07-13 IS IS1498A patent/IS722B6/en unknown
- 1965-07-13 FI FI651674A patent/FI45954C/en active
- 1965-07-13 NO NO158910A patent/NO117176B/no unknown
- 1965-07-14 AT AT804967A patent/AT266157B/en active
- 1965-07-14 AT AT805267A patent/AT269896B/en active
- 1965-07-14 CH CH990265A patent/CH469679A/en unknown
- 1965-07-14 AT AT805167A patent/AT269895B/en active
- 1965-07-14 AT AT646965A patent/AT266155B/en active
- 1965-07-14 AT AT805067A patent/AT266158B/en active
- 1965-07-14 AT AT804862A patent/AT276422B/en active
- 1965-07-15 OA OA52116A patent/OA02022A/en unknown
- 1965-07-15 MC MC573A patent/MC545A1/en unknown
- 1965-07-15 NL NL656509172A patent/NL149159B/en unknown
- 1965-07-16 JP JP40042827A patent/JPS4838698B1/ja active Pending
- 1965-07-16 BE BE667035A patent/BE667035A/xx unknown
- 1965-07-16 BR BR171355/65A patent/BR6571355D0/en unknown
- 1965-07-16 SE SE9415/65A patent/SE325020B/xx unknown
-
1966
- 1966-05-05 SE SE6161/66A patent/SE343297B/en unknown
- 1966-05-05 SE SE6160/66A patent/SE343296B/en unknown
- 1966-05-05 SE SE6159/66A patent/SE343295B/en unknown
- 1966-06-29 DK DK337366AA patent/DK118554B/en unknown
- 1966-06-29 DK DK337466AA patent/DK119456B/en unknown
- 1966-06-29 DK DK337566AA patent/DK119204C/en active
- 1966-06-29 DK DK337266AA patent/DK119203C/en active
-
1969
- 1969-03-28 CY CY47769A patent/CY477A/en unknown
- 1969-12-31 MY MY1969216A patent/MY6900216A/en unknown
-
1971
- 1971-05-18 SE SE03952/71A patent/SE358637B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0242851B1 (en) | N-(2'-aminophenyl)-benzamide derivatives, process for their manufacture and their application in the treatment of neoplastic illness | |
| HU184943B (en) | Process for producing sulfonyl-urea compounds and pharmaceutical compositions containing them | |
| EP0991626A2 (en) | Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds | |
| IL23351A (en) | Benzenesulphonyl-ureas and process for the manufacture thereof | |
| IL23909A (en) | Benzenesulfonyl-ureas and process for preparing them | |
| US3504026A (en) | Benzenesulfonyl-ureas | |
| US3488380A (en) | Carbamate esters and their method of preparation | |
| US3847938A (en) | Benzene-sulfonyl semicarbazides and process for preparing them | |
| US20040039045A1 (en) | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | |
| US3829434A (en) | Piperidinesulfonylurea derivatives | |
| US3546234A (en) | Benzene-sulfonyl-semicarbazides | |
| US3879403A (en) | Benzenesulfonylurea derivatives | |
| US3320312A (en) | Phenylsulfonyl cyclo-alkylureas and the preparation thereof | |
| US3754030A (en) | N - (4-(beta-<2-methoxy-5-chloro-benzamido>-ethyl) - benzenesulfonyl)-n'-cyclopentyl-urea and process for its manufacture | |
| US2941002A (en) | Beta-hydroxy carboxylic acid amides substituted at the nitrogen atom | |
| US3336322A (en) | Benzenesulfonyl ureas and process for their manufacture | |
| US3483297A (en) | Treatment of diabetes with benzenesulfonylcyclohexyl ureas | |
| US3509162A (en) | Phenethyl carbamates | |
| US3420882A (en) | Benzenesulfonyl ureas | |
| US3449417A (en) | Benzenesulphonyl-ureas and process for preparing them | |
| US3435116A (en) | The treatment of diabetes mellitus with benzenesulfonyl ureas | |
| US3448149A (en) | Benzenesulfonyl ureas | |
| US3096244A (en) | Substituted butyric acid amide and analgesia | |
| US3709908A (en) | Benzenesulfonyl ureas having hypoglycemic activity | |
| US3214467A (en) | Sulfonyl urea compounds and a process of making same |